INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 139 filers reported holding INTERSECT ENT INC in Q4 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $205,000 | -16.0% | 25,600 | -0.8% | 0.01% | -9.1% |
| Q4 2020 | $244,000 | – | 25,800 | +2245.5% | 0.01% | – |
| Q3 2020 | $0 | -100.0% | 1,100 | -97.9% | 0.00% | -100.0% |
| Q4 2019 | $636,000 | +61.4% | 52,684 | +15.7% | 0.04% | +8.3% |
| Q3 2019 | $394,000 | +58.2% | 45,531 | -3.1% | 0.04% | +50.0% |
| Q2 2019 | $249,000 | +88.6% | 47,000 | +32.8% | 0.02% | +71.4% |
| Q1 2019 | $132,000 | +78.4% | 35,400 | +1261.5% | 0.01% | +180.0% |
| Q3 2018 | $74,000 | -75.1% | 2,600 | -77.1% | 0.01% | -54.5% |
| Q2 2017 | $297,000 | +121.6% | 11,367 | +41.2% | 0.01% | +83.3% |
| Q1 2017 | $134,000 | +737.5% | 8,053 | +373.7% | 0.01% | +500.0% |
| Q4 2016 | $16,000 | +60.0% | 1,700 | -26.1% | 0.00% | – |
| Q3 2016 | $10,000 | +66.7% | 2,300 | +43.8% | 0.00% | – |
| Q2 2016 | $6,000 | -14.3% | 1,600 | +6.7% | 0.00% | – |
| Q1 2016 | $7,000 | +16.7% | 1,500 | +400.0% | 0.00% | – |
| Q4 2015 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |